Levothroid (Page 7 of 7)

PRINCIPAL DISPLAY PANEL — 112 mcg Tablet Bottle Label

NDC 0456-1330-01

Levothroid® (levothyroxine sodium tablets, USP)

112 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 112 mcg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 125 mcg Tablet Bottle Label

NDC 0456-1324-01

Levothroid® (levothyroxine sodium tablets, USP)

125 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 125 mcg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 137 mcg Tablet Bottle Label

NDC 0456-1331-01

Levothroid® (levothyroxine sodium tablets, USP)

137 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 137 mcg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 150 mcg Tablet Bottle Label

NDC 0456-1325-01

Levothroid® (levothyroxine sodium tablets, USP)

150 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 150 mcg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 175 mcg Tablet Bottle Label

NDC 0456-1326-01

Levothroid® (levothyroxine sodium tablets, USP)

175 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 175 mcg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 200 mcg Tablet Bottle Label

NDC 0456-1327-01

Levothroid® (levothyroxine sodium tablets, USP)

200 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 200 mcg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 300 mcg Tablet Bottle Label

NDC 0456-1328-01

Levothroid® (levothyroxine sodium tablets, USP)

300 mcg

Rx only

100 Tablets

LOT NO.

EXP.

Rev. 06-11

PRINCIPAL DISPLAY PANEL -- 300 mcg Tablet Bottle Label
(click image for full-size original)
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1320
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 25 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C YELLOW NO. 6
Product Characteristics
Color ORANGE (orange) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 25;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1320-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1321
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 50 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Product Characteristics
Color WHITE (white) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 50;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1321-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1322
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 75 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C RED NO. 40
FD&C BLUE NO. 2
Product Characteristics
Color PURPLE (Violet) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 75;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1322-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1329
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 88 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C YELLOW NO. 6
FD&C BLUE NO. 1
D&C YELLOW NO. 10
Product Characteristics
Color GREEN (mint green) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 88;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1329-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1323
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 100 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C YELLOW NO. 6
D&C YELLOW NO. 10
Product Characteristics
Color YELLOW (yellow) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 100;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1323-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1330
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 112 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
D&C RED NO. 27
D&C RED NO. 30
Product Characteristics
Color PINK (rose) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 112;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1330-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1324
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 125 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C BLUE NO. 1
FD&C RED NO. 40
FD&C YELLOW NO. 6
Product Characteristics
Color BROWN (brown) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 125;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1324-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1331
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 137 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C BLUE NO. 1
Product Characteristics
Color BLUE (deep blue) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 137;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1331-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1325
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 150 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C BLUE NO. 2
Product Characteristics
Color BLUE (blue) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 150;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1325-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1326
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 175 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C BLUE NO. 1
D&C RED NO. 27
D&C RED NO. 30
Product Characteristics
Color PURPLE (lilac) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 175;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1326-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1327
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 200 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C RED NO. 40
Product Characteristics
Color PINK (pink) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 200;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1327-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
LEVOTHROID levothyroxine sodium tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0456-1328
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 300 ug
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
POVIDONE K29/32
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
FD&C YELLOW NO. 6
FD&C BLUE NO. 1
D&C YELLOW NO. 10
Product Characteristics
Color GREEN (green) Score 2 pieces
Shape OVAL (caplet-shaped) Size 10mm
Flavor Imprint Code 300;T4
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0456-1328-01 100 TABLET (TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021116 10/16/2003
Labeler — Forest Laboratories, Inc. (001288281)
Establishment
Name Address ID/FEI Operations
LLOYD Inc. of Iowa 007281942 ANALYSIS (0456-1320), ANALYSIS (0456-1321), ANALYSIS (0456-1322), ANALYSIS (0456-1329), ANALYSIS (0456-1323), ANALYSIS (0456-1330), ANALYSIS (0456-1324), ANALYSIS (0456-1331), ANALYSIS (0456-1325), ANALYSIS (0456-1326), ANALYSIS (0456-1327), ANALYSIS (0456-1328)
Establishment
Name Address ID/FEI Operations
Peptido GmbH 327335410 API MANUFACTURE (0456-1320), API MANUFACTURE (0456-1321), API MANUFACTURE (0456-1322), API MANUFACTURE (0456-1329), API MANUFACTURE (0456-1323), API MANUFACTURE (0456-1330), API MANUFACTURE (0456-1324), API MANUFACTURE (0456-1331), API MANUFACTURE (0456-1325), API MANUFACTURE (0456-1326), API MANUFACTURE (0456-1327), API MANUFACTURE (0456-1328)
Establishment
Name Address ID/FEI Operations
Forest Pharmaceuticals 139645477 ANALYSIS (0456-1320), ANALYSIS (0456-1321), ANALYSIS (0456-1322), ANALYSIS (0456-1329), ANALYSIS (0456-1323), ANALYSIS (0456-1330), ANALYSIS (0456-1324), ANALYSIS (0456-1331), ANALYSIS (0456-1325), ANALYSIS (0456-1326), ANALYSIS (0456-1327), ANALYSIS (0456-1328), PACK (0456-1320), PACK (0456-1321), PACK (0456-1322), PACK (0456-1329), PACK (0456-1323), PACK (0456-1330), PACK (0456-1324), PACK (0456-1331), PACK (0456-1325), PACK (0456-1326), PACK (0456-1327), PACK (0456-1328), LABEL (0456-1320), LABEL (0456-1321), LABEL (0456-1322), LABEL (0456-1329), LABEL (0456-1323), LABEL (0456-1330), LABEL (0456-1324), LABEL (0456-1331), LABEL (0456-1325), LABEL (0456-1326), LABEL (0456-1327), LABEL (0456-1328)
Establishment
Name Address ID/FEI Operations
LLOYD Inc. of Iowa 962286535 MANUFACTURE (0456-1320), MANUFACTURE (0456-1321), MANUFACTURE (0456-1322), MANUFACTURE (0456-1329), MANUFACTURE (0456-1323), MANUFACTURE (0456-1330), MANUFACTURE (0456-1324), MANUFACTURE (0456-1331), MANUFACTURE (0456-1325), MANUFACTURE (0456-1326), MANUFACTURE (0456-1327), MANUFACTURE (0456-1328), PACK (0456-1320), PACK (0456-1321), PACK (0456-1322), PACK (0456-1329), PACK (0456-1323), PACK (0456-1330), PACK (0456-1324), PACK (0456-1331), PACK (0456-1325), PACK (0456-1326), PACK (0456-1327), PACK (0456-1328), LABEL (0456-1320), LABEL (0456-1321), LABEL (0456-1322), LABEL (0456-1329), LABEL (0456-1323), LABEL (0456-1330), LABEL (0456-1324), LABEL (0456-1331), LABEL (0456-1325), LABEL (0456-1326), LABEL (0456-1327), LABEL (0456-1328)

Revised: 01/2012 Forest Laboratories, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.